World Health Organization

Improved detection of drug-resistant TB using genetic and culture-based laboratory methods

24 October 2018, New York WHO and partners released a series of documents today to improve drug susceptibility testing for TB in laboratories worldwide.

Read More →

Public–private mix for TB prevention and care: a roadmap

First-ever targeted roadmap outlines steps to scale-up public-private health sector engagement to end TB.

Read More →

WHO and FIND: Technical guide on sequencing

Read More →

WHO and Global Fund sign framework agreement

The World Health Organization and the Global Fund today signed a Global Strategic Framework as a foundation for closer collaboration, based on respective mandates and strengths, and with commitment toward achieving the Sustainable Development Goals. It was signed by Dr. Tedros Adhanom Ghebreyesus, Director-General of WHO, and Peter Sands, Executive Director of the Global Fund.

Read More →

UN General Assembly adopts Declaration of the first-ever UN High-Level Meeting on TB

The World Health Organization (WHO)'s Global TB Program released a newsletter featuring highlights from the UN High-Level Meeting on TB, held on 26 September 2018.

Read More →

Frequently Asked Questions on the WHO Rapid Communication: key changes to the treatment of multidrug- and rifampicin-resistant TB

The World Health Organization (WHO) in collaboration with the Stop TB Partnership’s Global Drug Facility, the Global Fund to Fight AIDS, Tuberculosis and Malaria and the United States Agency for International Development have developed a set of frequently asked questions (and answers) in response to inquiries on upcoming WHO policy recommendations.

Read More →

New roadmap to end child and adolescent TB deaths

A new action plan outlines measures to prevent and treat TB in children and adolescents.

Read More →

WHO calls for urgent action to end TB

WHO’s 2018 Global TB Report calls for an unprecedented mobilization of national and international commitments; First-ever United Nations High-Level Meeting on TB provides historic opportunity.

Read More →

WHO announces landmark changes in MDR-TB treatment regimens

Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.

Read More →

Call for membership: Revamped WHO Civil Society Task Force on TB

Apply to be a member of the revamped World Health Organization (WHO) Civil Society Task Force on TB.

Read More →

Page 2 of 16 · Total posts: 10

←First 1 2 3 Last→